If the daily grind of subcutaneous injection of T-20 (Fuzeon) has got
you down, why not let your T-cells make their own -- with gene
therapy? Dorothee von Laer and Marc Egelhofer from Georg-Speyer-Haus
in Germany and colleagues recently reported on progress in
constructing a vehicle for an artificial gene called C36 that
produces a peptide with the same fusion-blocking sequence of T-20
(Fuzeon). The idea is to inject the gene, deliver it to blood cells,
and let the cells manufacture a new protective weapon against HIV to
place on their outer envelopes.

Full story at:
http://www.thebody.com/gmhc/issues/dec03/gene_therapy.html